CD274 and acute lymphoblastic leukemia: PD-L1 is able to be targeted as the TAA in this combination because of the need for signal 1 (provided by CD3xCD19 BsAb) for cytotoxic effect, restricting toxicity to B-ALL cells overexpressing PD-L1 [58].